Three-dimensional Ultrasound Applying in Assessment of Intrauterine Adhesions

NCT ID: NCT04930913

Last Updated: 2021-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-01

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective, multicenter, large-scale study,the investigators wish to examine the accuracy of several three-dimensional ultrasound anatomical and vascular parameters in diagnosing IUA when compared to the gold standard of hysteroscopy,and to assess the value of 3D US applying in prognosis of intrauterine adhesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Study Design This is a prospective, multicenter, large-scale diagnostic testing. We use hysteroscopy finding as standard reference.
2. Study population 600 patients from three tertiary hospitals suspected of having IUA will be prospectively recruited. Thorough assessment including previous reproductive and surgical history as well as menstrual pattern will be performed.
3. Study Procedure 3.1 Diagnosis

IUA will be diagnosed in coronal plane, based on a suggestion reported by a Taiwanese study. The morphological characteristics of the endometrium suggesting IUA include as follow:

* marginal irregularity (in coronal plane)
* defects (interrupted endometrial line)
* obliteration (undetectable endometrium suggesting extensive adhesion)
* fibrosis or calcification (hyperechoic lesion without posterior shadowing, or with posterior shadowing) 3.2 Ultrasound
* Transvaginal Ultrasound will be performed in luteal phase.
* Using E10 Voluson GE with 3D/4D TV probe.
* Scan and rendering will be performed in a standardized technique (omniview mode).
* Several parameters will be measured including endometrial volume, uterine volume, vascularization (VI FI VFI).

3.3 Hysteroscopy

* Hysteroscopic exam will be used as the gold standard for the diagnosis of intrauterine adhesions.
* hysteroscopy will confirm the presence, extent, and morphological characteristics of adhesions and the quality of the endometrium.

3.4 Surgical technique

* Hysteroscopic surgery will be performed in a standardized manner.
* The severity and extent of intrauterine adhesions will be scored according to different classification systems. (ESGE/AFS/China consensus)
* a Foley-catheter filled with 3.0ml normal saline will be inserted into the uterus for 5-7 days after surgery.

3.5 Postoperative treatments

* All subjects will be treated with Hormone therapy for at least 8 weeks
* A second-look hysteroscopy will be carried out 4 weeks after surgery, a third-look hysteroscopy will be carried out 12 weeks after surgery
* A second-look 3D US will be carried out in luteal phase after two menstrual peroid postoperatively.

3.6 Follow up

* Follow-up styles: the doctor's outpatient review, telephone, WeChat and so on.
* Follow-up time:3 months, 6months, 12 months after the operation.
* Follow up the results of hysteroscopy and 3D US at 3 months after the operation and the menstrual improvement at 6months after the operation and pregnancy outcomes at 12 months after the operation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrauterine Adhesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Three-dimensional Ultrasound

women suspected of having adhesions will perform 3D US

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women aged 20-40
* oligomenorrhea or amenorrhea
* BMI 18-30
* regular menstruation
* written consent obtained

Exclusion Criteria

* Hypothalamic amenorrhea, pituitary amenorrhea and ovarian amenorrhea
* Patients with uterine fibroids, adenomyosis, uterine malformation and endometrial polyps
* Patients with uterine artery embolization
* History of endometrial hyperplasia
* Irregular menstruation
* Patients with severe complications
* Patients with hypoovarian function
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fu Xing Hospital, Capital Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiaowu Huang

Director of department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Li Tinchiu

Role: STUDY_CHAIR

Fuxing Hospital,Capital Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fu Xing Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Huang xiaowu

Role: CONTACT

+8613810828816

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

luo wen

Role: primary

+86 010-88062291

References

Explore related publications, articles, or registry entries linked to this study.

Kim MJ, Lee Y, Lee C, Chun S, Kim A, Kim HY, Lee JY. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015 Dec;54(6):737-41. doi: 10.1016/j.tjog.2015.10.011.

Reference Type BACKGROUND
PMID: 26700995 (View on PubMed)

Amin TN, Saridogan E, Jurkovic D. Ultrasound and intrauterine adhesions: a novel structured approach to diagnosis and management. Ultrasound Obstet Gynecol. 2015 Aug;46(2):131-9. doi: 10.1002/uog.14927. Epub 2015 Jul 20. No abstract available.

Reference Type BACKGROUND
PMID: 26094824 (View on PubMed)

Carrascosa P, Capunay C, Vallejos J, Carpio J, Baronio M, Papier S. Two-dimensional and three-dimensional imaging of uterus and fallopian tubes in female infertility. Fertil Steril. 2016 Jun;105(6):1403-1420.e7. doi: 10.1016/j.fertnstert.2016.04.016. Epub 2016 Apr 29.

Reference Type BACKGROUND
PMID: 27140290 (View on PubMed)

AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg. 2017;14(1):6. doi: 10.1186/s10397-017-1007-3. Epub 2017 May 1. No abstract available.

Reference Type BACKGROUND
PMID: 28603474 (View on PubMed)

Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol. 2017 Aug;29(4):249-256. doi: 10.1097/GCO.0000000000000378.

Reference Type BACKGROUND
PMID: 28582327 (View on PubMed)

Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019 Mar 20;11:191-198. doi: 10.2147/IJWH.S165474. eCollection 2019.

Reference Type BACKGROUND
PMID: 30936754 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-1-7027

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prediction of Adhesion by Sliding Sign
NCT06841146 NOT_YET_RECRUITING NA